Stock A047920 HLB PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company HLB Pharmaceutical Co., Ltd.

Equities

A047920

KR7047920004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
34,300 KRW -1.72% Intraday chart for HLB Pharmaceutical Co., Ltd. +8.37% +125.51%
2023 HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors CI
2023 HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors CI

Business Summary

HLB Pharmaceutical Co Ltd, formerly Mediforum Pharmaceutical Inc, is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceutical products. The Company mainly manufactures and sells pharmaceutical products including cimetidine tablets, rozatin tablets, rabeprazole tablets, rozatinplus tablets, mosapia tablets and other ethical the counter (ETC) drugs; gynobetadine vaginal suppositories, and other over the counter (OTC) drugs; aceclofenac tablets, revotec tablets and other commissioned ETC drugs; L-carnitine tablets, elcatan tablets, hepatine liquids and other commissioned OTC drugs.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Manufacturing
99.7 %
107,307 99.8 % 135,598 99.7 % +26.36%
Others
0.3 %
175 0.2 % 355 0.3 % +102.86%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
107,482 100.0 % 135,953 100.0 % +26.49%

Managers

Managers TitleAgeSince
Jae-Hyeong Park CEO
 Chief Executive Officer 58 20-10-15
Bok-Hwan Jeon CEO
 Chief Executive Officer 60 20-10-15
Kang-Beom Kwon AUD
 Comptroller/Controller/Auditor 54 -
So-Gyung Joo PRN
 Corporate Officer/Principal 58 98-07-31

Members of the board

Members of the board TitleAgeSince
Tae-Hyeon Park BRD
 Director/Board Member 66 -
Jae-Hyeong Park CEO
 Chief Executive Officer 58 20-10-15
Bok-Hwan Jeon CEO
 Chief Executive Officer 60 20-10-15
Man-Gyu Kim BRD
 Director/Board Member 49 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,746,701 25,865,991 ( 81.48 %) 581 ( 0.001830 %) 81.48 %

Shareholders

NameEquities%Valuation
HLB LIFE SCIENCE CO., LTD.
13.65 %
4,322,044 13.65 % 118 M ₩
Yang-Gon Jin
2.485 %
786,535 2.485 % 22 M ₩
Jae-Hyeong Park
1.784 %
564,726 1.784 % 15 M ₩
Yu-rim Jin
0.3267 %
103,412 0.3267 % 3 M ₩
In-hye Jin
0.3267 %
103,412 0.3267 % 3 M ₩
Chul An Lim
0.0316 %
10,000 0.0316 % 273 352 ₩
HLB PHARMACEUTICAL CO., LTD.
0.001835 %
581 0.001835 % 15 882 ₩
Bok-Hwan Jeon
0.000000 %
0 0.000000 % - ₩
Man-Gyu Kim
0.000000 %
0 0.000000 % - ₩

Holdings

NameEquities%Valuation
HLB THERAPEUTICS CO.,LTD.
1.48%
 1,118,192 1.48% 11,229,678 $
HLB INNOVATION CO.,LTD.
2.93%
 2,074,688 2.93% 9,616,386 $
HLB PHARMACEUTICAL CO., LTD.
0.00%
 581 0.00% 15,882 $

Company contact information

HLB Pharmaceutical Co., Ltd.

27 Gyeonggang-ro

12244, Namyangju

+

http://www.hlbpharma.co.kr
address HLB Pharmaceutical Co., Ltd.(A047920)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
HLB PHARMACEUTICAL CO., LTD. Stock HLB Pharmaceutical Co., Ltd.
+125.51% 356M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.78% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.73% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.35% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.14% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A047920 Stock
  4. Company HLB Pharmaceutical Co., Ltd.